Effect of Vitamin D3 supplementation on respiratory tract infections in healthy individuals: A systematic review and meta-Analysis of randomized controlled trials

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Gysin, Danielle Vuichard ^a   Dao, Dyda ^a   Gysin, Christian Michael ^b   Lytvyn, Lyubov ^c   Loeb, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; PLACEBO;

DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; HUMAN; INFECTION PREVENTION; INFECTION RISK; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; META ANALYSIS; RESPIRATORY TRACT INFECTIONS;

CHOLECALCIFEROL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS;

EID: 84992425362     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162996     Document Type: Review

References (58)

1. D'Mello T, Brammer L, Blanton L, Kniss K, Smith S, Mustaquim D, et al. Update: Influenza activity-United States, September 28, 2014-February 21, 2015. MMWR Morbidity and mortality weekly report. 2015; 64(8):206-12. .
2. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. The New England journal of medicine. 2009; 360(6):588-98. doi: 10.1056/NEJMoa0804877 .
3. Heikkinen T, Jarvinen A. The common cold. Lancet. 2003; 361(9351):51-9. doi: 10.1016/S0140-6736 (03)12162-9 .
4. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-Analysis. Bmj. 2013; 347:f5061. doi: 10. 1136/bmj.f5061
5. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-Associated hospitalizations in the United States. JAMA: The journal of the American Medical Association. 2004; 292(11):1333-40. doi: 10.1001/jama.292.11.1333 .
6. Karve S, Misurski DA, Meier G, Davis KL. Employer-incurred health care costs and productivity losses associated with influenza. Human vaccines & immunotherapeutics. 2013; 9(4):841-57. doi: 10.4161/hv.23413
7. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: A systematic review and meta-Analysis. The Lancet infectious diseases. 2012; 12(1):36-44. doi: 10. 1016/S1473-3099(11)70295-X .
8. Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, Chen MH, et al. Comparing influenza vaccine efficacy against mismatched and matched strains: A systematic review and meta-Analysis. BMC Med. 2013; 11:153. doi: 10.1186/1741-7015-11-153
9. Larson EL, Ferng YH, Wong-McLoughlin J, Wang S, Haber M, Morse SS. Impact of non-pharmaceutical interventions on URIs and influenza in crowded, urban households. Public Health Rep. 2010; 125 (2):178-91.
10. Little P, Stuart B, Hobbs FD, Moore M, Barnett J, Popoola D, et al. An internet-delivered handwashing intervention to modify influenza-like illness and respiratory infection transmission (PRIMIT): A primary care randomised trial. Lancet. 2015. doi: 10.1016/S0140-6736(15)60127-1 .
11. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin Dmediated human antimicrobial response. Science. 2006; 311(5768):1770-3. doi: 10.1126/science. 1123933 .
12. Sundaram ME, Coleman LA. Vitamin D and influenza. Adv Nutr. 2012; 3(4):517-25. doi: 10.3945/an. 112.002162
13. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Archives of internal medicine. 2009; 169(4):384-90. doi: 10.1001/archinternmed.2008.560
14. Hirani V. Associations between vitamin D and self-reported respiratory disease in older people from a nationally representative population survey. Journal of the American Geriatrics Society. 2013; 61 (6):969-73. doi: 10.1111/jgs.12254 .
15. Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America. 2013; 57(3):392-7. doi: 10. 1093/cid/cit289
16. Bergman P, Lindh AU, Bjorkhem-Bergman L, Lindh JD. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PloS one. 2013; 8(6):e65835. doi: 10.1371/journal.pone.0065835
17. Charan J, Goyal JP, Saxena D, Yadav P. Vitamin D for prevention of respiratory tract infections: A systematic review and meta-Analysis. Journal of pharmacology & pharmacotherapeutics. 2012; 3(4):300-3. doi: 10.4103/0976-500X.103685
18. Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. The Journal of steroid biochemistry and molecular biology. 2013; 136:321-9. doi: 10.1016/j.jsbmb.2012.11.017 .
19. Mao S, Huang S. Vitamin D supplementation and risk of respiratory tract infections: A meta-Analysis of randomized controlled trials. Scandinavian journal of infectious diseases. 2013; 45(9):696-702. doi: 10.3109/00365548.2013.803293 .
20. Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: A systematic review of randomized controlled trials. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2009; 15(5):438-49. doi: 10.4158/EP09101.ORR
21. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-Analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015; 4:1. doi: 10.1186/2046-4053-4-1
22. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. The American journal of clinical nutrition. 1999; 69(5):842-56. .
23. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Bmj. 2011; 343:d5928. doi: 10.1136/bmj. d5928
24. Higgins JP, White IR, Anzures-Cabrera J. Meta-Analysis of skewed data: combining results reported on log-Transformed or raw scales. Stat Med. 2008; 27(29):6072-92. doi: 10.1002/sim.3427
25. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC medical research methodology. 2005; 5:13. doi: 10.1186/1471-2288-5-13
26. Grant CC, Kaur S, Waymouth E, Mitchell EA, Scragg R, Ekeroma A, et al. Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: A randomised controlled trial. Acta Paediatr. 2015; 104(4):396-404. doi: 10.1111/apa.12819 .
27. Neale R, Armstrong B, Ebeling P, English D, Kimlin M, Pols J, et al. Effect of vitamin d supplementation on antibiotic use and upper respiratory tract infection: A randomised controlled trial. American journal of epidemiology [Internet]. 2013; 177:[S131 p.]. Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/575/CN-01007575/frame.html
28. http://aje.oxfordjournals.org/content/177/suppl-11/S1.full.pdf.
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-Analyses. Bmj. 2003; 327(7414):557-60. doi: 10.1136/bmj.327.7414.557
30. Fleiss JL. The statistical basis of meta-Analysis. Stat Methods Med Res. 1993; 2(2):121-45. .
31. Altman DG, Bland JM. Interaction revisited: The difference between two estimates. Bmj. 2003; 326 (7382):219.
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-Analysis detected by a simple, graphical test. Bmj. 1997; 315(7109):629-34.
33. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. Bmj. 2004; 328(7454):1490. doi: 10.1136/bmj.328.7454.1490
34. Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiology & Infection. 2007; 135(7):1095-6; author reply 7-8.
35. de Gruijl FR, Pavel S. The effects of a mid-winter 8-week course of sub-sunburn sunbed exposures on tanning, vitamin D status and colds. Photochemical & Photobiological Sciences. 2012; 11(12):1848-54.
36. Dubnov-Raz G, Rinat B, Hemila H, Choleva L, Cohen AH, Constantini NW. Vitamin D supplementation and upper respiratory tract infections in adolescent swimmers: A randomized controlled trial. Pediatric exercise science. 2015; 27(1):113-9. doi: 10.1123/pes.2014-0030 .
37. Goodall EC, Granados AC, Luinstra K, Pullenayegum E, Coleman BL, Loeb M, et al. Vitamin D3 and gargling for the prevention of upper respiratory tract infections: A randomized controlled trial. BMC infectious diseases. 2014; 14:273. doi: 10.1186/1471-2334-14-273
38. Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamäki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: A randomized, double-blinded trial among young Finnish men. Journal of infectious diseases [Internet]. 2010; 202(5):[809-14 pp.]. Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/390/CN-00751390/frame.html
39. http://jid.oxfordjournals.org/content/202/5/809.full.pdf
40. Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiology & Infection. 2009; 137(10):1396-404. .
41. Murdoch DR, Slow S, Chambers ST, Jennings LC, Stewart AW, Priest PC, et al. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: The VIDARIS randomized controlled trial. JAMA: The journal of the American Medical Association [Internet]. 2012; 308(13):[1333-9 pp.]. Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/672/CN-00832672/frame.html
42. http://jama.jamanetwork.com/data/Journals/JAMA/24997/joc120088-1333-1339.pdf
43. Rees JR, Hendricks K, Barry EL, Peacock JL, Mott LA, Sandler RS, et al. Vitamin D3 supplementation and upper respiratory tract infections in a randomized, controlled trial. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America. 2013; 57(10):1384-92. doi: 10.1093/cid/cit549
44. Simpson S, van der Mei I, Stewart N, Blizzard L, Tettey P, Taylor B. Weekly cholecalciferol supplementation results in significant reductions in infection risk among the vitamin D deficient: results from the CIPRIS pilot RCT. BMC Nutrition. 2015; 1(7).
45. Urashima M, Mezawa H, Noya M, Camargo CA Jr. Effects of vitamin D supplements on influenza A illness during the 2009 H1N1 pandemic: A randomized controlled trial. Food & function. 2014; 5(9):2365-70. doi: 10.1039/c4fo00371c .
46. Manaseki-Holland S, Maroof Z, Bruce J, Mughal MZ, Masher MI, Bhutta ZA, et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: A randomised controlled superiority trial. Lancet [Internet]. 2012; 379(9824):[1419-27 pp.]. Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/163/CN-00814163/frame.html
47. http://www. Thelancet.com/pdfs/journals/lancet/PIIS0140-6736(11)61650-4.pdf
48. Camargo CA, Ganmaa D, Frazier AL, Kirchberg FF, Stuart JJ, Kleinman K, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics [Internet]. 2012; 130(3):[e561-7 pp.]. Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/086/CN-00968086/frame.html
49. http://pediatrics.aappublications.org/content/130/3/e561.full.pdf.
50. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. American journal of clinical nutrition [Internet]. 2010; 91(5):[1255-60 pp.]. Available: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/988/CN-00752988/frame.html
51. http://ajcn.nutrition.org/content/91/5/1255.full.pdf
52. Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, et al. Vitamin D is required for IFNgamma-mediated antimicrobial activity of human macrophages. Sci Transl Med. 2011; 3(104):104ra2. doi: 10.1126/scitranslmed.3003045
53. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiology & Infection. 2006; 134(6):1129-40.
54. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: A randomized trial. Annals of internal medicine. 2012; 156(2):105-14. doi: 10.7326/0003-4819-156-2-201201170-00004 .
55. Martineau AR, Hanifa Y, Witt KD, Barnes NC, Hooper RL, Patel M, et al. Double-blind randomised controlled trial of vitamin D3 supplementation for the prevention of acute respiratory infection in older adults and their carers (ViDiFlu). Thorax. 2015. doi: 10.1136/thoraxjnl-2015-206996 .
56. Roth DE, Jones AB, Prosser C, Robinson JL, Vohra S. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. The Journal of infectious diseases. 2008; 197(5):676-80. doi: 10.1086/527488 .
57. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2011; 96(7):1911-30. doi: 10.1210/jc.2011-0385 .
58. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010; 182 (17):1864-73. doi: 10.1503/cmaj.100771